Figure 3. RNAi-mediated knockdown and phenotypic analysis.
Survival plots of daf-2 mutants treated with (A) lbp-3 siRNA or (B) K02D7.1 siRNA and compared to a vector-treated control. (C) Dauer-arrest assay comparing the percent dauer formation of daf-2 mutants with RNAi-mediated knockdown of lbp-3 and K02D7.1 compared to a vector-treated control. (D) RT-PCR of daf-2 mutants treated with lbp-3 or K02D7.1 siRNA using primers for lbp-3, K02D7.1, or pmp-3 as a control.